Cargando…
Current progress and challenges in the design and development of a successful COVID-19 vaccine
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is still a worldwide concern, with little to no sign of a decreasing trend. There is a general consensus that normal life will be hampered until a safe and effective vaccine stra...
Autores principales: | Li, Tingting, Zhang, Tianying, Gu, Ying, Li, Shaowei, Xia, Ningshao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835609/ http://dx.doi.org/10.1016/j.fmre.2021.01.011 |
Ejemplares similares
-
Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022) -
A review of the safety and efficacy of current COVID-19 vaccines
por: Huang, Zehong, et al.
Publicado: (2022) -
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020) -
Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020) -
Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)